Cargando…

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Despite the advances in pre-, peri- and post-operative medical care of colorectal carcinoma patients, the prognosis has improved only marginally over recent decades. Thus, additional prognostic indicators would be of great clinical value to select patients for adjuvant therapy. In previous studies w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesh, S., Sier, C. F., Heerding, M. M., van Krieken, J. H., Griffioen, G., Welvaart, K., van de Velde, C. J., Verheijen, J. H., Lamers, C. B., Verspaget, H. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223607/
https://www.ncbi.nlm.nih.gov/pubmed/9192984
_version_ 1782149429910831104
author Ganesh, S.
Sier, C. F.
Heerding, M. M.
van Krieken, J. H.
Griffioen, G.
Welvaart, K.
van de Velde, C. J.
Verheijen, J. H.
Lamers, C. B.
Verspaget, H. W.
author_facet Ganesh, S.
Sier, C. F.
Heerding, M. M.
van Krieken, J. H.
Griffioen, G.
Welvaart, K.
van de Velde, C. J.
Verheijen, J. H.
Lamers, C. B.
Verspaget, H. W.
author_sort Ganesh, S.
collection PubMed
description Despite the advances in pre-, peri- and post-operative medical care of colorectal carcinoma patients, the prognosis has improved only marginally over recent decades. Thus, additional prognostic indicators would be of great clinical value to select patients for adjuvant therapy. In previous studies we found that colorectal carcinomas have a marked increase of the urokinase-type of plasminogen activator (u-PA), and the inhibitors PAI-1 and PAI-2, whereas the tissue-type plasminogen activator (t-PA) is found to be decreased in comparison with adjacent normal mucosa. In the present study we evaluated the prognostic value of several plasminogen activation parameters, determined in both normal and carcinomatous tissue from colorectal resection specimens, for overall survival of 136 Dukes' stage B and C colorectal cancer patients, in relation to major clinicopathological parameters. Uni- and multivariate analyses indicated that a high PAI-2 antigen level in carcinoma, a low t-PA activity and antigen level and a high u-PA/t-PA antigen ratio in adjacent normal mucosa are significantly associated with a poor overall survival. A high ratio of u-PA antigen in the carcinomas and t-PA antigen in normal mucosa, i.e. u-PA(C)/t-PA(N), was found to be predictive of a poor overall survival as well. All these parameters were found to be prognostically independent of the clinicopathological parameters. Multivariate analysis of combinations of these prognostically significant plasminogen activation parameters revealed that they are important independent prognostic indicators and have in fact a better prognostic value than their separate components. Based on these combined parameters, subgroups of patients with Dukes' stage B and C colorectal cancer could be identified as having either a high or a low risk regarding overall survival. In conclusion, these findings emphasize the relevance of the intestinal plasminogen activation system for survival prognosis of patients with colorectal cancer and, in the future, might constitute a patient selection criterion for adjuvant therapy.
format Text
id pubmed-2223607
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-22236072009-09-10 Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer. Ganesh, S. Sier, C. F. Heerding, M. M. van Krieken, J. H. Griffioen, G. Welvaart, K. van de Velde, C. J. Verheijen, J. H. Lamers, C. B. Verspaget, H. W. Br J Cancer Research Article Despite the advances in pre-, peri- and post-operative medical care of colorectal carcinoma patients, the prognosis has improved only marginally over recent decades. Thus, additional prognostic indicators would be of great clinical value to select patients for adjuvant therapy. In previous studies we found that colorectal carcinomas have a marked increase of the urokinase-type of plasminogen activator (u-PA), and the inhibitors PAI-1 and PAI-2, whereas the tissue-type plasminogen activator (t-PA) is found to be decreased in comparison with adjacent normal mucosa. In the present study we evaluated the prognostic value of several plasminogen activation parameters, determined in both normal and carcinomatous tissue from colorectal resection specimens, for overall survival of 136 Dukes' stage B and C colorectal cancer patients, in relation to major clinicopathological parameters. Uni- and multivariate analyses indicated that a high PAI-2 antigen level in carcinoma, a low t-PA activity and antigen level and a high u-PA/t-PA antigen ratio in adjacent normal mucosa are significantly associated with a poor overall survival. A high ratio of u-PA antigen in the carcinomas and t-PA antigen in normal mucosa, i.e. u-PA(C)/t-PA(N), was found to be predictive of a poor overall survival as well. All these parameters were found to be prognostically independent of the clinicopathological parameters. Multivariate analysis of combinations of these prognostically significant plasminogen activation parameters revealed that they are important independent prognostic indicators and have in fact a better prognostic value than their separate components. Based on these combined parameters, subgroups of patients with Dukes' stage B and C colorectal cancer could be identified as having either a high or a low risk regarding overall survival. In conclusion, these findings emphasize the relevance of the intestinal plasminogen activation system for survival prognosis of patients with colorectal cancer and, in the future, might constitute a patient selection criterion for adjuvant therapy. Nature Publishing Group 1997 /pmc/articles/PMC2223607/ /pubmed/9192984 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Ganesh, S.
Sier, C. F.
Heerding, M. M.
van Krieken, J. H.
Griffioen, G.
Welvaart, K.
van de Velde, C. J.
Verheijen, J. H.
Lamers, C. B.
Verspaget, H. W.
Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
title Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
title_full Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
title_fullStr Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
title_full_unstemmed Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
title_short Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
title_sort contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with dukes' stage b and c colorectal cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223607/
https://www.ncbi.nlm.nih.gov/pubmed/9192984
work_keys_str_mv AT ganeshs contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT siercf contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT heerdingmm contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT vankriekenjh contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT griffioeng contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT welvaartk contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT vandeveldecj contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT verheijenjh contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT lamerscb contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer
AT verspagethw contributionofplasminogenactivatorsandtheirinhibitorstothesurvivalprognosisofpatientswithdukesstagebandccolorectalcancer